PIN#81623Y0340 Due:
DOHMH, intends to enter into a Sole Source agreement with DIXON-SHANE LLC R&S NORTHEAST LLC., for the purchase of FDA approved Mifepristone Tablets, 200 mg abortion medication. In accordance with purchasing by DOHMH’s Bureau of Public Health Clinics (BPHC), In order to mitigate the threat to public health posed by the recent supreme court decision that overturned Roe vs Wade, which provided a constitutional right to abortion. Mifepristone is used, together with another medication called misoprostol, to end early pregnancy. DOHMH has determined that DIXON-SHANE LLC R & S NORTHEAST LLC is an exclusive distributor of Mifepristone tablets, and it is the only product listed for Marketing.
Any vendor who believes that they may also be able to provide this goods product in the future, is welcome to submit an expression of interest via email to Mnapolitano@health.nyc.gov. Any questions regarding this Sole Source contract should be addressed in writing to the contracting officer identified below.
Health and Mental Hygiene, 42-09 28th Street, 17th Floor, Queens, NY 11101-4132. Marcella Napolitano (347) 396-6680; Fax: (347) 396-6759; mnapolitano@health.nyc.gov